Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • DarvinD Offline
    DarvinD Offline
    Darvin
    wrote on sidst redigeret af
    #931

    Akkurat som TheNote skriver om TÁ, så tyder meget andet på ny medvind. Gnsn kursmål i 2.550 og højst sandsynligt stigende. Analytikerne skal lige kigge på egne tal og nyeste nyt, så mon ikke vi får flere revurderinger. “Up where we belong” 😄

    1 Reply Last reply
    0
    • DarvinD Offline
      DarvinD Offline
      Darvin
      wrote on sidst redigeret af
      #932

      Who knows what tomorrow brings
      In a world few hearts survive
      All I know is the way I feel
      When it's real, I keep it alive
      The road is long
      There are mountains in our way
      But we climb a step every day
      Love lift us up where we belong
      Where the eagles cry
      On a mountain high
      Love lift us up where we belong
      Far from the world below

      Up where the clear winds blow

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #933

        God morgen. 🙂

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #934

          Onsdagens aviser med Danske Bank, Genmab og Gyldendal
          https://www.proinvestor.com/investornyt/674235/onsdagens-aviser-med-danske-bank-genmab-og-gyldendal

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GeorgeBest
            wrote on sidst redigeret af
            #935

            Roche Q1 Investor presentation. Ocrevus på side 23

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #936

              MS franchise: Ocrevus with 26% total US market share
              Market leadership maintained

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #937

                Side 51 fase 3 studier hvor Mosunetuzumab og Glofitamab er med

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GeorgeBest
                  wrote on sidst redigeret af
                  #938

                  Iflg side 52 forventes Mosunetuzumab submitted i år og Glofitamab næste år

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #939

                    Godmorgen @GB. Hvorfor sælger Ocrevus så lidt uden for US?

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      GeorgeBest
                      wrote on sidst redigeret af
                      #940

                      Det ved jeg ikke

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #941

                        Du ved ellers så meget 🙂 Jeg leder på egen hånd

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Plimsoller
                          wrote on sidst redigeret af
                          #942

                          @LLI De har nok glemt at oversætte indlægssedlen ;-
                          )

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #943

                            mosunetuzumab
                            3L+ FL NME submission is shown in 2021,
                            mosunetuzumab +
                            lenalidomide 2L FL NME submission is shown in '2024 and beyond'

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #944

                              glofitamab
                              3L+ DLBCL 2022, glofitamab + chemo
                              2L DLBCL >2024

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #945

                                Thx EL - no time to stop and smell the flowers

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #946

                                  Is Glofi going after DLBCL and Mosune after FL ?

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #947

                                    it looks like that for the first filings, but we
                                    know glofi also has FL expansian cohorts and vice versa, so maybe it is too early to say? presentation shows the trials https://www.roche.com/dam/jcr:3a48ad2b-c695-462c-a42f-ffcae34fa39c/en/irp210421.pdf

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #948

                                      Ocrevus had 25% total US market share in the Q4 report, so that sort of stayed the same

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #949

                                        Er der nogen, der har set recepttal?

                                        1 Reply Last reply
                                        0
                                        • D Offline
                                          D Offline
                                          deleted-user
                                          wrote on sidst redigeret af
                                          #950

                                          @E L world wide isn't that impressive?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger